|
⚲
|
| Keyboard |
| Nuechterlein Carole
✚
|
|
|---|---|
| CIK # | 0001665133 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001665133] | |
| 4 | [0001665133] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aligos Therapeutics Inc | |
| Nuechterlein Carole | |
| Entrada Therapeutics Inc | |
| Tango Therapeutics Inc | |
| Tempest Therapeutics Inc | |
| AveXis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 5,860 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-06-27 | Grant | 60,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-28 | Grant | 4,411 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2024-02-27 | Disposed to issuer | 15,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Warrant (Right to Buy) · derivative
|
2023-10-25 | Buy | 3,966,800 | $0.13 | 515,684 |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2023-10-25 | Buy | 7,933,601 | $0.76 | 6,029,537 |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2023-07-20 | Grant | 20,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2022-06-23 | Grant | 15,000 | $0.00 | |
|
Entrada Therapeutics Inc TRDA
Stock Option (Right to Buy) · derivative
|
2022-06-02 | Grant | 11,918 | $0.00 | |
|
Entrada Therapeutics Inc TRDA
Stock Option (Right to Buy) · derivative
|
2021-10-28 | Grant | 23,552 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Stock Option (Right to Buy) · derivative
|
2021-06-17 | Grant | 15,000 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series A Preferred Stock · derivative
|
2020-10-20 | Conversion | 2,145,991 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Series B-2 Preferred Stock · derivative
|
2020-10-20 | Conversion | 283,550 | $0.00 | |
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 662,799 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 283,550 | ||
|
Aligos Therapeutics Inc ALGS
Common Stock
|
2020-10-20 | Conversion | 2,145,991 | ||
|
Aligos Therapeutics Inc ALGS
Series B-1 Preferred Stock · derivative
|
2020-10-20 | Conversion | 662,799 | $0.00 | |
|
Tempest Therapeutics Inc MLND
Stock Option (right to buy) · derivative
|
2020-06-22 | Grant | 12,000 | $0.00 | |
|
Tempest Therapeutics Inc MLND
Stock Option (right to buy) · derivative
|
2019-06-20 | Grant | 12,000 | $0.00 | |
|
Tempest Therapeutics Inc MLND
Stock Option (right to buy) · derivative
|
2019-01-15 | Grant | 6,000 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||